在中度严重到急性严重性结肠炎的胰岛素敏感性
Daniel Bergemalm1, Bayar Baban2, Olle Ljungqvist2
1Department of Gastroenterology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
Scandinavian journal of gastroenterology
|January 30, 2025
概括
患有严重性结肠炎 (UC) 的患者因炎症和葡萄糖皮质类药物 (GCs) 而出现胰岛素抵抗. 胰岛素敏感性在缓解后得到改善,这表明这些因素导致UC患者的代谢障碍.
科学领域:
- 胃肠病学 胃肠病学
- 内分泌学 在内分泌学.
- 代谢研究研究 代谢研究
背景情况:
- 患有中度至重度性结肠炎 (UC) 的住院患者可能会出现代谢障碍.
- 炎症和葡萄糖皮质体 (GC) 治疗与UC患者的胰岛素抵抗有关.
研究的目的:
- 在住院患者中评估胰岛素敏感性中,中度重度至重度UC.
- 为了比较活跃疾病爆发和缓解期间的胰岛素敏感性.
主要方法:
- 试点研究涉及住院患者中度至重度活跃UC.
- 用于胰岛素敏感性量化使用的高胰岛素性优糖 (HEC) 方法.
- 在活跃爆发和无类固醇缓解期间评估胰岛素敏感性,与健康对照进行比较.
主要成果:
- 所有五名参与UC患者在活跃爆发期间都显示胰岛素敏感性显著降低.
- 降低胰岛素敏感性持续不论治疗结果 (infliximab或切除术).
- 在实现缓解后,胰岛素敏感性正常化到与健康对照人相似的水平.
结论:
- 患有中度重度至重度UC的患者在活跃爆发期间表现出显著的胰岛素抵抗.
- 炎症和GC治疗都可能导致UC的胰岛素抵抗.
- 在缓解期恢复胰岛素敏感性表明可逆代谢障碍.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
310
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
310
Drugs for Treatment of Ulcerative Colitis in IBD
118
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
118
Insulin: Dosing Regimen and Adverse Effects
141
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
141
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.1K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.1K
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
95
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
95
Inflammatory Bowel Disease I: Ulcerative Colitis
131
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
131


